The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Ubiquitin-dependent Destruction of Topoisomerase I Is Stimulated by the Antitumor Drug Camptothecin
Open accessAbstract
Topoisomerase I (TOP1) relaxes superhelical DNA through a breakage/rejoining reaction in which the active site tyrosine links covalently to a 3' phosphate at the break site as a transient intermediate. The antitumor drug camptothecin (CPT) and its analogs inhibit the rejoining step of the breakage/rejoining reaction, which traps the enzyme in covalent linkage with DNA (the cleavable complex). Little is known about the fate of cellular TOP1 trapped in the cleavable complex. We have analyzed TOP1 in mammalian cell lines treated with CPT. When CPT-treated cells were lysed with either SDS or alkali and analyzed by Western blotting, greater than 90% of the TOP1 was linked to DNA. Nuclease treatment of the cell lysate to remove the covalently linked DNA from TOP1 revealed a distinct ladder of higher molecular weight bands having properties indicative of multi-ubiquitin (Ub) conjugates of TOP1. Approximately 5-10% of TOP1 was present as these conjugates within minutes of CPT treatment. Consistent with ubiquitination, TOP1 was not modified in ts85 cells at the restrictive temperature for its thermolabile ubiquitin-activating enzyme (E1). Because conjugation with ubiquitin can mark proteins for destruction by the 26S proteasome, we analyzed TOP1 protein levels during prolonged CPT treatment. TOP1 protein levels were reduced to about 25% during CPT treatments of 2-4 h resulting from increased destruction, with the half-life dropping from 10-16 h down to 1-2 h. The destruction of TOP1, like the formation of Ub-TOP1 conjugates, was not observed in ts85 cells at the restrictive temperature. The destruction of TOP1 was also prevented in cells treated with MG-132 and lactacystin, specific inhibitors of the 26S proteasome. Finally, the multi-Ub conjugates of TOP1 were observed whether or not aphidicolin was included in cotreatment with CPT, indicating that replication fork activity was not involved in making TOP1 a substrate for ubiquitination. These results demonstrate that independent of DNA replication, the TOP1 cleavable complex is ubiquitinated and destroyed in cells treated with antitumor drugs that block the religation step of the TOP1 reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular Cloning. A Laboratory Manual
Wood, E. (1983) · Biochemical Education · doi:10.1016/0307-4412(83)90068-7 · Cited by 29,533
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Self-citationThe ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
Wang, J. C. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003313 · Cited by 1,540
Hsiang, Y. H., Lihou, M. G., & Liu, L. F. (1989) · PubMed · Cited by 1,028
Self-citationHsiang, Y. H., & Liu, L. F. (1988) · PubMed · Cited by 841
Self-citationA Proteolytic Pathway That Recognizes Ubiquitin as a Degradation Signal
Johnson, E. S., Ma, P. C. M., Ota, I. M., & Varshavsky, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17442 · Cited by 821
A 26 S protease subunit that binds ubiquitin conjugates.
Deveraux, Q., Ustrell, V., Pickart, C., & Rechsteiner, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37244-7 · Cited by 761
Hertzberg, R. P., Caranfa, M. J., & Hecht, S. M. (1989) · Biochemistry · doi:10.1021/bi00437a018 · Cited by 551
Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85
Finley, D., Ciechanover, A., & Varshavsky, A. (1984) · Cell · doi:10.1016/0092-8674(84)90299-x · Cited by 522
Finley, D., & Chau, V. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.000325 · Cited by 439
The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins.
Loeb, K. R., & Haas, A. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42585-9 · Cited by 435
Topoisomerase-targeting antitumor drugs
D'Arpa, P., & Liu, L. F. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(89)90041-3 · Cited by 434
Self-citationSolomon, V., & Goldberg, A. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26690 · Cited by 429
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
D’Arpa, P., Beardmore, C., & Liu, L. F. (1990) · PubMed · Cited by 425
Self-citationDifferential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
Heck, M. M., Hittelman, W. N., & Earnshaw, W. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1086 · Cited by 409
Lee, D. H., & Goldberg, A. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27280 · Cited by 406
Holm, C., Covey, J. M., Kerrigan, D., & Pommier, Y. G. (1989) · PubMed · Cited by 366
Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
Zhang, H., Wang, J. C., & Liu, L. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1060 · Cited by 284
Self-citationProtein Degradation or Regulation: Ub the Judge
Hochstrasser, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81058-2 · Cited by 279
D'Arpa, P., Machlin, P. S., Ratrie, H., Rothfield, N. F., Cleveland, D. W., & Earnshaw, W. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2543 · Cited by 261
Self-citationArnason, T., & Ellison, M. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7876 · Cited by 232
Baboshina, O. V., & Haas, A. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2823 · Cited by 225
Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome.
Fleischmann, G., Pflugfelder, G., Steiner, E. K., Javaherian, K., Howard, G. C., Wang, J. C., & Elgin, S. C. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6958 · Cited by 222
Avemann, K., Knippers, R., Koller, T., & Sogo, J. M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3026 · Cited by 211
Topoisomerase I interacts with transcribed regions in Drosophila cells
Gilmour, D. S., Pflugfelder, G., Wang, J. C., & Lis, J. T. (1986) · Cell · doi:10.1016/0092-8674(86)90461-7 · Cited by 208
Tsao, Y., Russo, A. A., Nyamuswa, G., SILBER, R. H., & Liu, L. F. (1993) · PubMed · Cited by 206
Self-citationCiechanover, A., & Schwartz, A. L. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119489 · Cited by 202
Cook, W. J., Jeffrey, L. C., Carson, M., Chen, Z., & Pickart, C. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42026-1 · Cited by 192
Cook, W. J., Jeffrey, L. C., Carson, M., Chen, Z., & Pickart, C. M. (1993) · Worldwide Protein Data Bank · doi:10.2210/pdb1aar/pdb · Cited by 186
Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription
Davie, J., & Murphy, L. C. (1990) · Biochemistry · doi:10.1021/bi00472a002 · Cited by 158
Conjugation of the 15-kDa Interferon-induced Ubiquitin Homolog Is Distinct from That of Ubiquitin
Narasimhan, J., Potter, J. L., & Haas, A. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.324 · Cited by 150
Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation
Grant, E. P., Michalek, M. T., Goldberg, A. L., & Rock, K. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3750 · Cited by 142
Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription
Bendixen, C., Thomsen, B., Alsner, J., & Westergaard, O. (1990) · Biochemistry · doi:10.1021/bi00475a028 · Cited by 140
Gilmour, D. S., & Elgin, S. C. R. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.1.141 · Cited by 136
Functional diversity among putative E2 isozymes in the mechanism of ubiquitin-histone ligation.
Haas, A. L., Bright, P. M., & Jackson, V. E. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37700-7 · Cited by 115
van Nocker, S., & Vierstra, R. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74530-x · Cited by 93
Ribosome Formation is Blocked by Camptothecin, a Reversible Inhibitor of RNA Synthesis
Wu, R. S., Kumar, A., & Warner, J. R. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.12.3009 · Cited by 84
Porter, S. E., & Champoux, J. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.2.541 · Cited by 67
Synthetic Signals for Ubiquitin-Dependent Proteolysis
Sadis, S., Atienza, C. A., & Finley, D. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4086 · Cited by 61
Hodgins, R., Gwozd, C., Arnason, T., Cummings, M. D., & Ellison, M. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28766 · Cited by 55
Isolation, Characterization, and Partial Purification of a Novel Ubiquitin-Protein Ligase, E3
Gonen, H., Stancovski, I., Shkedy, D., Hadari, T., Bercovich, B., Bengal, E., Mesilati, S., Hatoum, O. A., Schwartz, A. L., & Ciechanover, A. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.302 · Cited by 39
Cited by
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
Adams, J., & Kauffman, M. (2004) · Cancer Investigation · doi:10.1081/cnv-120030218 · Cited by 654
All tangled up: how cells direct, manage and exploit topoisomerase function
Vos, S. M., Tretter, E. M., Schmidt, B. H., & Berger, J. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3228 · Cited by 650
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
Cohen, A. A., Geva-Zatorsky, N., Eden, E., Frenkel-Morgenstern, M., Issaeva, I., Sigal, A., Milo, R., Cohen-Saidon, C., Liron, Y., Kam, Z., et al. (2008) · Science · doi:10.1126/science.1160165 · Cited by 596
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
Pommier, Y., Pourquier, P., Fan, Y., & Strumberg, D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00129-8 · Cited by 551
Mechanism of Action of Camptothecin
Liu, L. F., Duann, P., Lin, C., D'Arpa, P., & Wu, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb26375.x · Cited by 508
Self-citation
Metadata
- Authors
- Desai, S. D., Liu, L. F., Vazquez-Abad, D., & D'Arpa, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-09
- Volume
- 272
- Issue
- 39
- Pages
- 24159-24164
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2085901921
- Cited by
- 269
- References
- 44
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.